The new capital will be used for growth initiatives and general corporate purposes.
Frist Capital is a private investment company investing the assets of a Nashville family.
Matthew Bulow, founder and chief clinical officer of Bulow BioTech, said: “This investment furthers our mission of becoming one of the world’s leading patient care providers for prosthetic applications and helping our patients live their lives to the fullest.”